Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases

AIM: To date, neither the benefit of mycophenolic acid (MPA) therapeutic drug monitoring (TDM), the prodrug of mycophenolate mofetil (MMF), nor the optimal monitoring technique have been established in autoimmune diseases. This study was undertaken to confirm, in a cohort of new patients, the plasma...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Clin Pharmacol
Huvudupphovsmän: Streicher, Caroline, Djabarouti, Sarah, Xuereb, Fabien, Lazaro, Estibaliz, Legeron, Rachel, Bouchet, Stéphane, Greib, Carine, Breilh, Dominique, Pellegrin, Jean-Luc, Viallard, Jean-François
Materialtyp: Artigo
Språk:Inglês
Publicerad: BlackWell Publishing Ltd 2014
Ämnen:
Pharmacokinetic Dynamic Relationships
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256630/
https://ncbi.nlm.nih.gov/pubmed/25041114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12462
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk